139 related articles for article (PubMed ID: 10482797)
21. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity.
Klivenyi P; Andreassen OA; Ferrante RJ; Lancelot E; Reif D; Beal MF
Neuroreport; 2000 Apr; 11(6):1265-8. PubMed ID: 10817604
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.
Hantraye P; Brouillet E; Ferrante R; Palfi S; Dolan R; Matthews RT; Beal MF
Nat Med; 1996 Sep; 2(9):1017-21. PubMed ID: 8782460
[TBL] [Abstract][Full Text] [Related]
24. Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.
Rose S; Hindmarsh JG; Jenner P
J Neural Transm (Vienna); 1999; 106(5-6):477-86. PubMed ID: 10443551
[TBL] [Abstract][Full Text] [Related]
25. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
Gilad GM; Gilad VH; Finberg JP; Rabey JM
Neurochem Res; 2005; 30(6-7):713-9. PubMed ID: 16187208
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
27. 2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain.
Chan P; Langston JW; Irwin I; DeLanney LE; Di Monte DA
J Neurochem; 1993 Aug; 61(2):610-6. PubMed ID: 8336145
[TBL] [Abstract][Full Text] [Related]
28. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Gaál J; Solti M; Kollár E; Singer J
J Neural Transm Suppl; 1994; 41():207-19. PubMed ID: 7931228
[TBL] [Abstract][Full Text] [Related]
29. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
Finnegan KT; Irwin I; Delanney LE; Langston JW
J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
[TBL] [Abstract][Full Text] [Related]
30. The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats.
Czarnecka A; Konieczny J; Lenda T; Lorenc-Koci E
Brain Res; 2015 Nov; 1625():218-37. PubMed ID: 26319690
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
Wu WR; Zhu XZ; Guan HJ; Wang RG; Ji XQ
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):146-50. PubMed ID: 10437162
[TBL] [Abstract][Full Text] [Related]
32. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
Thiffault C; Lamarre-Théroux L; Quirion R; Poirier J
Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
[TBL] [Abstract][Full Text] [Related]
34. Implication of poly (ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism. Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide.
Cosi C; Marien M
Ann N Y Acad Sci; 1999; 890():227-39. PubMed ID: 10668429
[TBL] [Abstract][Full Text] [Related]
35. Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice.
Ito T; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):121-5. PubMed ID: 21788124
[TBL] [Abstract][Full Text] [Related]
36. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
Gal S; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
[TBL] [Abstract][Full Text] [Related]
37. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
Shahi GS; Das NP; Moochhala SM
Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Delanney LE; Irwin I; Langston JW
J Pharmacol Exp Ther; 1992 Apr; 261(1):44-9. PubMed ID: 1560384
[TBL] [Abstract][Full Text] [Related]
39. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice.
Kupsch A; Gerlach M; Pupeter SC; Sautter J; Dirr A; Arnold G; Opitz W; Przuntek H; Riederer P; Oertel WH
Neuroreport; 1995 Mar; 6(4):621-5. PubMed ID: 7605913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
